<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">brca1-related-gene-signature-in-breast-cancer-the</item><item key="name">BRCA1-related gene signature in breast cancer: the role of ER status and molecular type</item><item key="sample_count">41</item><item key="tags"><item>basal</item><item>brca1</item><item>breast</item><item>breast cancer</item><item>cancer</item><item>disease</item><item>estrogen</item><item>liquid</item><item>luminal</item><item>ovarian cancer</item><item>protein</item><item>sporadic breast cancer</item></item><item key="id">2297</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-50567</item><item key="species">human</item><item key="factor_count">7</item></item><item><item key="slug">chac1-mrna-expression-is-a-strong-prognostic-bioma</item><item key="name">CHAC1 mRNA expression is a strong prognostic biomarker in breast and ovarian cancer</item><item key="sample_count">12</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>disease</item><item>hormone</item><item>median</item><item>ovarian cancer</item><item>protein</item><item>serum</item></item><item key="id">3741</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-22865</item><item key="species">human</item><item key="factor_count">2</item></item><item><item key="slug">changes-in-follistatin-levels-by-brca1-may-serve-a</item><item key="name">Changes in follistatin levels by BRCA1 may serve as a regulator of ovarian carcinogenesis</item><item key="sample_count">6</item><item key="tags"><item>brca1</item><item>breast</item><item>breast cancer</item><item>cancer</item><item>carcinoma</item><item>ovarian cancer</item><item>ovarian carcinoma</item><item>protein</item><item>surface</item></item><item key="id">4148</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-30296</item><item key="species">human</item><item key="factor_count">0</item></item><item><item key="slug">chromatin-h3k27me3h3k4me3-histone-marks-define-gen</item><item key="name">Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high grade serous ovarian cancer that distinguish malignant, tumour sustaining and chemo-resistant ovarian tumour cells.</item><item key="sample_count">9</item><item key="tags"><item>cancer</item><item>cell</item><item>ovarian cancer</item></item><item key="id">4594</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-41500</item><item key="species">human</item><item key="factor_count">4</item></item><item><item key="slug">col11a1-promotes-tumor-progression-and-predicts-po</item><item key="name">COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.</item><item key="sample_count">60</item><item key="tags"><item>cancer</item><item>cell</item><item>collagen</item><item>disease</item><item>ovarian cancer</item><item>protein</item></item><item key="id">2159</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-44104</item><item key="species">human</item><item key="factor_count">4</item></item><item><item key="slug">differential-gene-expression-profiles-between-skov</item><item key="name">Differential gene expression profiles between SKOV3.ip1-S116A cells (Ser116 of PEA-15 substituted with alanine) and SKOV3.ip1-S116D cells (Ser116 of PEA-15 substituted with aspartic acid).</item><item key="sample_count">6</item><item key="tags"><item>alanine</item><item>aspartic acid</item><item>cancer</item><item>ovarian cancer</item><item>protein</item></item><item key="id">4487</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-37934</item><item key="species">human</item><item key="factor_count">2</item></item><item><item key="slug">expression-data-from-non-malignant-fallopian-tube</item><item key="name">Expression data from non-malignant fallopian tube epithelium</item><item key="sample_count">24</item><item key="tags"><item>brca1</item><item>cancer</item><item>ovarian cancer</item><item>point</item></item><item key="id">4001</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-28044</item><item key="species">human</item><item key="factor_count">3</item></item><item><item key="slug">expression-data-from-ovarian-surface-kinome</item><item key="name">Expression Data from Ovarian Surface Kinome</item><item key="sample_count">17</item><item key="tags"><item>cancer</item><item>ovarian cancer</item><item>protein</item><item>surface</item></item><item key="id">3244</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-15578</item><item key="species">human</item><item key="factor_count">1</item></item><item><item key="slug">expression-data-from-serous-ovarian-carcinomas-ser</item><item key="name">Expression data from serous ovarian carcinomas, serous ovarian borderline tumors and surface epithelium scrapings from normal ovaries</item><item key="sample_count">12</item><item key="tags"><item>cancer</item><item>ovarian cancer</item><item>serum</item><item>superficial</item></item><item key="id">4445</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-36668</item><item key="species">human</item><item key="factor_count">0</item></item><item><item key="slug">expression-data-from-skov3-cells-treated-with-saha</item><item key="name">Expression data from SKOV3 cells treated with SAHA or vehicle control</item><item key="sample_count">8</item><item key="tags"><item>cancer</item><item>ovarian cancer</item></item><item key="id">2098</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-53603</item><item key="species">human</item><item key="factor_count">2</item></item></data></biogps>
